In February 2023, the court was considering final pretrial motions for the upcoming June 2023 trial. Additionally, two other significant lawsuits were scheduled to go to trial later in the [...]
A major development occurred when U.S. District Judge Wendy Beetlestone set the date for the first trial in the Injectafer litigation, scheduled to begin on June 5, 2023. While the [...]
As lawsuits against Injectafer continued to move forward in the Eastern District of Pennsylvania, many plaintiffs claimed that the drug manufacturer failed to warn about the risks associated with the [...]
A study published in August 2019 lent support to the growing number of lawsuits against Injectafer, confirming that the drug can cause hypophosphatemia (HPP), a condition in which phosphorus levels [...]
Injectafer
Rating 4.8 / 5.0 (3400 total reviews)
